Despite all other alternative interventions that would prevent or reduce the formation of TMAO, the combination of choline TMA lyase and potent FMO3 inhibitors is being considered because it could provide optimal therapeutic effects with fewer side effects in inhibiting atherosclerosis formation and plaque rupture. Here, FMO3 is linked to atherosclerosis.